Brief: Labcorp Unveils New Name for Future Independent Clinical Development Business
Feb 9 (Reuters) - Laboratory Corporation of America
Holdings LH.N :
* LABCORP - NEW COMPANY TO BE FORMED BY PLANNED SPIN-OFF OF
ITS
CLINICAL DEVELOPMENT BUSINESS WILL BE KNOWN AS FORTREA
* LABCORP - SPIN-OFF REMAINS ON TRACK TO BE COMPLETED IN
MID-2023
Source text for Eikon: ID:nBw2bzc1ya
Further company coverage: LH.N
Recent news on Laboratory of America Holdings
See all newsBrief: Labcorp To Announce Second Quarter 2026 Financial Results On July 30, 2026
Brief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health